SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ajanta Pharma informs about participation in investor conference

08 Aug 2024 Evaluate
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ajanta Pharma has informed about the schedule of Analyst/Institutional Investor Meeting with the Company on 12-August-24. The schedule of the above-mentioned meetings is subject to change and the change may occur due to exigencies on either side. Further confirmed that the discussion during these meetings will be strictly on the basis of already published information and no Unpublished Price Sensitive Information is proposed to be discussed in these meetings.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2779.55 -10.60 (-0.38%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×